Qualitative data mining of past market research is a valuable adjunct to conventional market analysis, allowing hindsight to become foresight
08/02/2012
FEATURE
Deal watch: A look at the biggest mergers and acquisitions from 2011, including Sanofi's purchase of Genzyme and J&J taking over Synthes
03/02/2012
FEATURE
Currently facing a major financial crisis, Spain's healthcare system is overstretched with autonomous regions owing millions of Euros to suppliers such as the pharma industry
27/01/2012
FEATURE
Therapies are facing greater scrutiny to ensure they do not carry increased risk of cardiovascular side effects
27/01/2012
FEATURE
A survey of pharma companies shows they are hiring expert help to cope with the problems of an increasingly fragmented market in the UK
24/01/2012
FEATURE
Patients seldom refuse therapy outright, but often show a reluctance to comply. Understanding the reasons for this is the first step to improving their treatment
23/01/2012
FEATURE
The new regulation has caught many in the industry off guard and the European Medicines Agency has given companies just months to respond to this mandate, one of the most expansive regulatory reforms in decades
17/01/2012
FEATURE
GE Healthcare's president and CEO tells Dominic Tyer about the rising importance of molecular diagnostics and how his company is moving increasingly closer to the biopharmaceutical world
16/01/2012
FEATURE
Though an attractive market potentially, this country has a slow registration procedure and an emphasis on drug cost rather than value
11/01/2012
FEATURE
Pharmaceutical public relations fulfils a much more important role than just creating promotional adverts; it is a vital adjunct in educating patients about drugs and diseases
10/01/2012
FEATURE
Drug companies are opting to buy firms to access their technologies or products
09/01/2012
FEATURE
The EU's financial crisis has put focus on tighter budgets, so there is no better time to understand how to boost a drug's attractiveness
05/01/2012
FEATURE
A decade after the discovery of an activating mutation in the BRAF gene showed the feasibility of targeted therapies, four new drugs, as well as their combinations, offer exciting possibilities
03/01/2012
FEATURE
The challenges, goals and developments for the pharma industry within attention deficit hyperactivity disorder (ADHD)
23/12/2011
FEATURE
Pharmacuetical companies must comply with increasingly stronger legislation from regulatory authorities
21/12/2011
FEATURE
Interest in percutaneous methods of drug delivery is reviving now that molecules with higher weight can be administered using electrical current, infrared, ultrasound and microwaves
19/12/2011
FEATURE
Exploring the industry's most important dates, we recall December 1942: First trial involving chemotherapy
16/12/2011
FEATURE
While doctors cannot be rewarded for prescribing a particular drug, there is still a lot marketers can do to promote decision makers' engagement with a product
15/12/2011
FEATURE
Collaborative initiative to support the specific needs of young patients with type 1 diabetes
14/12/2011
FEATURE
While Europe has been getting to grips with standards for presenting drug data, US regulators have been equally busy bringing the industry closer to full electronic submissions
13/12/2011
FEATURE